DarioHealth Corp (DRIO)vsTempus AI, Inc. Class A Common Stock (TEM)
DRIO
DarioHealth Corp
$6.63
-2.07%
HEALTHCARE · Cap: $67.91M
TEM
Tempus AI, Inc. Class A Common Stock
$85.01
+3.37%
HEALTHCARE · Cap: $14.50B
Smart Verdict
WallStSmart Research — data-driven comparison
Tempus AI, Inc. Class A Common Stock generates 6720% more annual revenue ($1.43B vs $21.00M). TEM leads profitability with a -17.8% profit margin vs -169.9%. TEM earns a higher WallStSmart Score of 28/100 (F).
DRIO
Avoid23
out of 100
Grade: F
TEM
Avoid28
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+7.4%
Fair Value
$11.88
Current Price
$6.63
$5.25 discount
Intrinsic value data unavailable for TEM.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Every $100 of equity generates 101 in profit
Revenue surging 21.6% year-over-year
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
Revenue declined 3.6%
0.0% earnings growth
Trading at 34.4x book value
ROE of -57.2% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : DRIO
The strongest argument for DRIO centers on Price/Book, Return on Equity.
Bull Case : TEM
The strongest argument for TEM centers on Revenue Growth. Revenue growth of 21.6% demonstrates continued momentum.
Bear Case : DRIO
The primary concerns for DRIO are EPS Growth, Market Cap, Piotroski F-Score.
Bear Case : TEM
The primary concerns for TEM are EPS Growth, Price/Book, Return on Equity. Debt-to-equity of 3.25 is elevated, increasing financial risk.
Key Dynamics to Monitor
DRIO profiles as a turnaround stock while TEM is a growth play — different risk/reward profiles.
TEM carries more volatility with a beta of 3.72 — expect wider price swings.
TEM is growing revenue faster at 21.6% — sustainability is the question.
DRIO generates stronger free cash flow (-6M), providing more financial flexibility.
Bottom Line
TEM scores higher overall (28/100 vs 23/100) and 21.6% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
DarioHealth Corp
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
DarioHealth Corp. The company is headquartered in New York, New York.
Visit Website →Tempus AI, Inc. Class A Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Tempus AI, Inc is a healthcare technology company. The company is headquartered in Chicago, Illinois.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?